Now On Air

Liberty #MAGAOne Mix

Via MAGA One Mix

6:00 am 8:00 am


Upcoming shows
Real News

NOW ON AIR
Now On Air

Liberty #MAGAOne Mix

Via MAGA One Mix

6:00 am 8:00 am



Maga First News

Upcoming Shows

Join The MAGA Network on Discord

0 0

Trump says Democrats have become 'anti-Jewish' party, calls bigotry resolution a 'disgrace'

President Trump accused Democrats on Friday of becoming an “anti-Israel” and “anti-Jewish” party, after the House passed a broad resolution that called out bigotry of all kinds without directly condemning freshman Rep. Ilhan Omar for allegedly anti-Semitic remarks.

From the White House lawn before departing for Alabama on Friday, the president called Thursday’s House vote a “disgrace.”

HOUSE PASSES BROAD RESOLUTION CALLING OUT RACISM, 'ANTI-SEMITIC,' COMMENTS --WITHOUT NAMING ILHAN OMAR

“Democrats have become an anti-Israel party. They’ve become an anti-Jewish party,” Trump said. “I think the vote was a disgrace.”

The president said that most lawmakers would agree that the resolution, which did not mention Omar, D-Minn., by name, was a disgrace “if you get an honest answer.”

The final vote on the resolution was 407 to 23—with 23 Republicans voting no, and all Democrats, including Omar, voting yes. The final draft of the resolution was expanded Thursday afternoon to condemn all forms of bigotry, including white supremacy, in what Republicans characterized as a ploy to distract from Omar’s remarks which had prompted the resolution in the first place.

“Today’s resolution vote was a sham put forward by Democrats to avoid condemning one of their own and denouncing vile anti-Semitism,” House Republican Conference Chair Liz Cheney, R-Wy., said Thursday. “While I stand whole heartedly against discrimination outlined in this resolution, the language before the House today did not address the issue front and center.”

Cheney was among the 23 Republicans who did not support the resolution.

OMAR RETWEETS POST BLASTING MEGHAN MCCAIN FOR 'FAUX OUTRAGE' IN RESPONSE TO OMAR'S REMARKS ON ISRAEL

Meanwhile, Omar and Reps. Rashida Tlaib, D-Mich., Rep. Andre Carson of Indiana called the vote “historic.”

“Today is historic on many fronts,” they said in a statement. “It’s the first time we have voted on a resolution condemning Anti-Muslim bigotry in our nation’s history.”

The measure originally was drafted in response to Omar suggesting that Israel supporters want U.S. lawmakers to pledge “allegiance” to the Jewish state – which was widely condemned as echoing the age-old “dual loyalties” smear against Jewish politicians.

CLICK HERE TO GET THE FOX NEWS APP

Omar also tweeted in 2012 that “Israel hypnotized the world, may Allah awaken the people and help them see the evil doings of Israel.” Omar apologized for her comments and deleted the tweet.

"Anti-Semitism is real and I am grateful for Jewish allies and colleagues who are educating me on the painful history of anti-Semitic tropes,” she said.

Fox News’ Gregg Re and The Associated Press contributed to this report.

Source: Fox News Politics

0 0

Osaka breezes past Hsieh to reach Stuttgart last eight

Tennis: BNP Paribas Open-Day 9
FILE PHOTO: Mar 12, 2019; Indian Wells, CA, USA; Naomi Osaka (JPN) as she was defeated in her fourth round match against Belinda Bencic (not pictured) in the BNP Paribas Open at the Indian Wells Tennis Garden. Mandatory Credit: Jayne Kamin-Oncea-USA TODAY Sports

April 25, 2019

BERLIN (Reuters) – World number one Naomi Osaka made a winning start to her claycourt season by beating Taiwan’s Hsieh Su-wei 6-4 6-3 on Thursday to move into the quarter-finals of the Porsche Tennis Grand Prix.

The twice grand slam champion, who has yet to win a title on clay, found little resistance as she avenged her defeat to Hsieh in Miami last month.

A break was enough for Osaka to win the first set as she looked somewhat uncomfortable on Stuttgart’s quick indoor clay, designed to be similar to next month’s French Open courts.

There was nothing wrong with her serve, however, as she fired seven aces during the contest.

After going 2-0 up in the second set, Osaka grew in confidence and broke again to seal her first win on clay this season on her first match point.

Victory also meant she will hold on to her world number one ranking after this week.

Osaka will next face Croatia’s Donna Vekic who beat Daria Kasatkina 6-1 7-5.

Former world number one Victoria Azarenka of Belarus will take on fourth seed and defending champion Karolina Pliskova for a spot in the quarter-finals later on Thursday.

(Reporting by Karolos Grohmann, editing by Pritha Sarkar)

Source: OANN

0 0

Disturbing Increase in Colorectal Cancer in Young Adults

This article is dedicated to Breanne and Aston in hopes that efforts to identify what is driving this new epidemic of colorectal cancer in our children will lead not only to more effective treatments, but ultimately prevent this devastating disease.

I’m well aware of colorectal cancer in that the disease personally touched my mother in her 70s and my brother in his late 50s. But I was not aware of the alarming new trend of young adults in their 20s and 30s being diagnosed with this devastating disease. Recently, two of my friends in their early thirties have had their lives touched by colon cancer. Before this turn of events, they were incredibly healthy, athletic and taking on the world! Now, they are instead bravely facing surgery, chemotherapy and major lifestyle changes in an effort to regain their health.

A recent WebMD article acknowledged that one of the most significant and disturbing developments in colorectal cancer is the marked increase in younger individuals (which is decades before the American Cancer Society recommends people get screened for the disease). According to the article, by 2030, colorectal cancer incidence rates will be up 90% in people between ages 20 and 34, and 28% for people between ages 35 and 49. What is even more concerning is that often they are not diagnosed until later stages of the disease because most doctors are not thinking “cancer” when a young adult complains of abdominal pain or rectal bleeding.

Researchers describe this upward trend, which began in the late 1980s, as “ominous” and “worrisome.” Although the conventional wisdom is that risk for colorectal cancer (also referred to as colon, bowel or rectal cancer) increases with age, the rate at which adults over age 50 are being diagnosed has been declining. A 2017 study showed that those born around 1990 (i.e., currently in their late twenties) “have double the risk of colon cancer…and quadruple the risk of rectal cancer” compared with adults born around 1950. Similar patterns are playing out in other countries, with worldwide colon cancer deaths expected to increase by 60% by 2035, “especially among younger people.”

Why would Gen Xers and millennials increasingly be presenting with colorectal malignancies once deemed rare in the young? Most observers seem to be “grasping at straws” when it comes to furnishing an explanation. Some want to pin the blame on obesity as a “prime suspect”—but obesity cannot explain why colorectal cancers are repeatedly cropping up in healthy young athletes in “peak physical shape.” A leading oncologist whose colorectal cancer patients are mostly under age 40 recently confessed, “It’s hard to blame it on obesity alone. We suspect there is also something else going on.” The oncologist did not venture to guess what the “something else” might be.

According to the American Cancer Society, it takes anywhere from 10 to 15 years for an abnormal cell in the lining of the colon to develop into cancer. This means that the first abnormal cell growth that resulted in cancer occurred during childhood. Therefore, it is essential that we look at potential culprits and exposures occurring in childhood.

There are two possible contributors that temporally coincide not only with the spike in young adult colorectal cancers but also with the horrifying increase in childhood cancers. The first is the vaccine schedule’s inclusion of more viral vaccines since the late 1980s, and the known fact that viral vaccines are prone to various forms of contamination. Second, over the same time period, young people’s exposure to glyphosate has exploded, wreaking havoc with their gut bacteria—and intestinal imbalances have a well-documented association with colorectal cancer. In this article, I discuss the vaccine contamination issue; in Part II, I will consider glyphosate and the colorectal cancer crisis.


Alex exposes the globalist agenda that uses government agencies to cover up crimes against the population.

Learning From History

Viral vaccines have been plagued with problems of contamination since their earliest days, and, as Children’s Health Defense has discussed previously, these problems furnish a plausible link between vaccines and cancer. In fact, an independent website devoted to this topic describes the vaccine-cancer connection as “the biggest medical scandal in history,” making the crucial point that vaccine scientists’ use of contaminated cell lines from “the very birth of virology” has been “perpetuating and causing cancer” for decades. The Institute of Medicine tacitly acknowledged this in 2002 when it cited biological evidence supporting the theory that contamination of polio vaccines with simian virus 40 (SV40)—vaccines that were administered to millions of Americans in the late 1950s and early 1960s—“could contribute to human cancers.”

In the mid-1950s, Jonas Salk used the world’s most famous laboratory cells—HeLa cells—to develop his initial polio vaccine. Scientists had just succeeded in creating the cells—the first “immortal” (meaning endlessly cloned) human cell line—by feeding a cancer victim’s (Henrietta Lacks’) highly malignant cervical cancer cells with a nutrient mix containing blood and tissue from human placenta, beef embryo and live chicken heart. To the researchers’ delight, the HeLa cells responded to this treatment by multiplying “indefinitely” instead of aging.

However, researchers and government regulators soon backed off from the use of HeLa cells in vaccine production, deeming their malignant characteristics of rapid and immortal cell growth “not acceptable…for vaccine development” due to the “theoretical risk of transmitting cancer.” To produce viral vaccines, they instead relied on living animal cells that they erroneously perceived as safer, including the monkey cell line used in later iterations of Salk’s vaccine and other living cell types such as chicken embryos.

In Salk’s day, scientists may not have realized that their laboratory hodge-podge of animal and human blood and tissue was secretly facilitating the incorporation of “known and unknown viruses and bacteria” into their cell lines, nor that the HeLa cells themselves were capable of aggressively contaminating other cell lines—but a whistleblower named Walter Nelson-Rees later showed that this was in fact the case. Nelson-Rees proved in the 1970s that, very early on, Salk’s monkey cell line had been “invaded and taken over” by HeLa cells, and Salk unknowingly injected the contaminants into some of his human subjects. More recently, scientist Judy Mikovits has catalogued the risks of using animal tissues and cells to grow human viruses for viral vaccine production, stating that “re-injecting that material back into humans could introduce new animal viruses into the human population.”

Circling Back to Tumor Cells

For many years, Nelson-Rees and others persisted in trying to draw attention to the cell culture contamination problem, to little avail. In fact, rather than heed these conscientious researchers’ cautions, the Food and Drug Administration’s (FDA’s) vaccine regulators, in 2012, characterized the “current repertoire” of animal-derived cell lines as “inadequate” and proposed a startlingly risky about-face. Ignoring the past problems with HeLa cells and other forms of cell culture contamination, the FDA suggested that “cell lines derived from tumors may be the optimal and in some cases the only cell substrate that can be used to propagate certain vaccine viruses.

Matching deeds to words, the FDA also wasted no time in approving, that same year, the first cell-based influenza vaccine, hawking it to the public by praising its apparently superior performance compared to traditional egg-based flu vaccines. The Flucelvax vaccine is made from an immortal cell line “derived from a dog kidney and known to be tumorigenic in mice.” On its website, the FDA discreetly admits that “latent” cancer-causing viruses could potentially be present in these tumor-based cell lines and could pose a threat, “since they might become active under vaccine manufacturing conditions.” The agency also notes that latent viruses are “hard to detect using standard methods.”

The rapid approval of immortalized cell line vaccines stands in stark contrast to an internal document that I wrote about last year in which a leading FDA official contended, in 1999, that modern advances in vaccine technology were rapidly outpacing the ability to predict potential vaccine-related adverse events. The official argued for closer attention to safety issues from the earliest stages of vaccine development. “One of the important things is that the technology used to make these vaccines actually exceeds the science and technology to understand how these vaccines work and to predict how they will work,” stated Dr. Peter Patriarca, MD, Director of the Viral Products Division of the FDA Center for Biologics Evaluation and Research (CBER). While scientists use continuous cell lines for their ability to be propagated and grow viruses to a higher titer, Patriarca acknowledged that “the worst thing we are concerned about is malignancy, because some of these continuous cells even have the potential for growing tumors in laboratory animals.”

(Photo by Rubén Díaz / Flickr)

Something Old, Something New?

In an article describing pathogenic vaccine contamination, one author points to evidence that immortal cell lines “react differently” to various animal species, even when the species are “closely related,” and asks whether vaccine contaminants may likewise affect groups of people (such as the elderly versus infants) differently. This is an interesting question, given that one of the notable features of the colorectal cancers appearing in twenty- and thirty-somethings is that the malignancies often exhibit more biological aggressiveness than the colorectal cancers observed in older adults. One study reported that a unique type of cancer cell called “signet cell histology”—cells that “migrate more freely and exhibit a more aggressive mode of spread”—was nearly five times more prevalent in rectal cancer patients under age 40 than in older patients.

Other researchers have used high-throughput DNA sequencing techniques to make similar observations. Those methods reveal “different rates of genetic alterations” between adolescent and young adult colorectal cancer patients compared to older adults, “indicating potential molecular differences in the disease state and suggesting the need for alternative treatment strategies in younger patients.” Certainly, the American Cancer Society’s colorectal cancer screening recommendations, revised downward from age 50 to age 45 in 2018, will do little to help identify these aggressive cancers in younger adults.

Under the U.S. vaccine schedule, children receive numerous and recurrent doses of viral vaccines cultured in either human, monkey, bovine or chicken cells or in a multispecies combination of these cell types. These include viral vaccines against chickenpox, hepatitis, polio, rotavirus and measles-mumps-rubella. Compared to adults, young people have far greater exposure to these viral vaccines—and their inevitable contaminants. Could this have something to do with the age-related molecular differences being observed in colorectal cancers? No one really knows, because while the pharmaceutical industry is busily trying to develop cancer vaccines, it does not make a practice of assessing existing vaccines’ cancer risks. The all-too-typical disclaimer contained in most vaccine package inserts states that the vaccine “has not been evaluated for carcinogenic or mutagenic potential.”

The unacceptably high numbers of young adults who, in the prime of life, are being sidelined by debilitating colorectal cancers is a red flag telling us that we need to do better. We must find answers for what is causing this new epidemic of cancer in our children and what can be done to prevent it from occurring.

The viewpoints expressed here do not necessarily represent those of Infowars.


Alex Jones coins a new word while breaking down how elites manipulate online comments to control content creators.

Source: InfoWars

0 0

Major currencies tread water ahead of euro zone, China data

FILE PHOTO: U.S. dollars and other world currencies lie in a charity receptacle at Pearson international airport in Toronto
FILE PHOTO: U.S. dollars and other world currencies lie in a charity receptacle at Pearson international airport in Toronto, Ontario, Canada June 13, 2018. REUTERS/Chris Helgren/File Photo

April 16, 2019

By Daniel Leussink

TOKYO (Reuters) – Major currencies remained confined to well-trodden ranges on Tuesday, as markets look next to European and Chinese data for more evidence that the worst may be over for the global economy.

The yen remained close to 2019 lows against the U.S. and Australian dollars after investors reduced exposure to the safe-haven currency to seek higher yields elsewhere.

The Japanese currency has fallen against both units after rising to recent highs in late March, said Masafumi Yamamoto, chief currency strategist at Mizuho Securities.

“That’s probably because the market’s concern about the global economy is easing and also the U.S.-China trade war will not intensify further,” he said.

The dollar was unchanged at 112.00 yen, holding above its 200-day moving average for the fourth straight session.

It traded less than a sixth of a percent off the year’s high of 112.135 yen hit in early March.

The Aussie was basically flat at 80.35 yen, also trading above its 200-day moving average, for the third session, after last breaching the key technical level in December last year.

The data in focus includes Germany’s ZEW economic index for April, due around 0900 GMT, and China’s gross domestic product set for Wednesday, which is expected to offer more insight on the health of the world’s second-largest economy. Chinese exports and credit data last week signaled some stabilization, prompting markets to adjust their outlook on global growth.

Market participants eyed European manufacturing data due on Thursday for cues on whether growth in that region is improving.

The euro was steady at $1.1307 after inching up less than a tenth of a percent overnight.

The dollar index last stood at 96.932 after ending the previous session basically unchanged.

Investors also kept their focus on trade issues, including talks between Japanese Economy Minister Toshimitsu Motegi and U.S. Trade Representative Robert Lighthizer.

Motegi said late on Monday both sides had confirmed that new bilateral trade talks would proceed based on the two nations’ joint statement issued last September. Motegi and Lighthizer are slated to continue their talks on Tuesday.

Meanwhile, U.S. Treasury Secretary Steven Mnuchin said over the weekend he hoped Sino-U.S. trade negotiations were close to their final round.

Reuters reported on Sunday that U.S. negotiators had tempered demands that China curb industrial subsidies as a condition for a trade deal after strong resistance from Beijing.

The Australian dollar, a barometer of investor sentiment, was unchanged at $0.7174, hovering close to a near seven-week high brushed on Friday.

Mizuho’s Yamamoto said traders were unwinding bets on two interest rate cuts in 2019 by Australia’s central bank to counter the country’s slowing economic growth.

“The unwinding of that expectation is happening now. That’s why it’s supporting the Australian dollar,” he said.

(Editing by Jacqueline Wong)

Source: OANN

0 0

Zimbabwe seeks $613 million aid from donors after drought, cyclone

FILE PHOTO: A man gestures next to his car after it was swept into debris left by Cyclone Idai in Chimanimani, Zimbabwe
FILE PHOTO: A man gestures next to his car after it was swept into debris left by Cyclone Idai in Chimanimani, Zimbabwe, March 23, 2019. REUTERS/Philimon Bulawayo/File Photo

April 9, 2019

HARARE (Reuters) – Zimbabwe appealed on Tuesday for $613 million in aid from local and foreign donors to cover food imports and help with a humanitarian crisis after a severe drought and a cyclone that battered the east of the country.

An El Nino-induced drought has wilted crops across Zimbabwe and left about a third of its 15 million people in need of food assistance, according to a U.N. agency.

The situation was worsened when Zimbabwe, along with Mozambique and Malawi, were last month battered by Cyclone Idai, leaving hundreds of thousands needing food, water and shelter.

An appeal document given to reporters by the ministry of information showed the government is seeking about $300 million in aid for food while the rest would fund emergency shelters, logistics and telecommunications among other needs.

Hundreds of people have died in Mozambique and Malawi and the death toll in Zimbabwe was now 344.

Meanwhile, Information Minister Monica Mutsvangwa said the cabinet had hiked the maize price paid to farmers by 86 percent to $232 a tonne and maintained a subsidy for millers in a bid to keep the price of the staple maize meal down.

In February, Zimbabwe scrapped a 1:1 peg between the U.S. dollar and the bond notes and electronic dollars it introduced to compensate for its hard currency shortage, merging the surrogate currencies into the RTGS dollar.

Mutsvangwa said farmers would be paid 726 RTGS dollars ($232), up from 390 RTGS dollars.

The RTGS dollar was trading at 3.12 to the U.S. dollar on Tuesday on the bank market and at 4.4 on the black market.

The government is the sole buyer and seller of maize in Zimbabwe through the state-owned Grain Marketing Board.

(Reporting by MacDonald Dzirutwe; Editing by Mark Heinrich)

Source: OANN

0 0

Republican Rep. Adam Kinzinger condems 'awful' New Zealand attack, says 'thoughts and prayers matter' after attack

Rep. Adam Kinzinger, R-Ill., Friday called the mass shootings at two New Zealand mosques "awful" and expressed he was troubled by the social media role in the event.

"Anybody being attacked is terrible. When you focus on someone because of their faith at their place of worship, it's especially disheartening," Kinzinger said on "Fox & Friends."

At least 49 people were killed in mass shootings at two Christchurch mosques full of worshippers attending Friday prayers on what the prime minister called "one of New Zealand's darkest days.

One man was arrested and charged with murder in what appeared to be a carefully planned hate crime. Police also defused explosive devices in a car.

The alleged shooter, who describes himself as a racist, wrote a lengthy anti-immigrant manifesto.

CHRISTCHURCH RESIDENT RECALLS AIDING GUNSHOT VICTIM WHO FLED FROM MASS SHOOTING

"Thoughts and prayers and we mean it. Thoughts and prayers are impactful.  Please pray for the people that are going through this," Kinznger added.

Co-host Brian Kilmeade brought up a tweet made by Rep. Alexandria Ocasio-Cortez, D-N.Y., dismissing 'thoughts and prayers.'

"What good are your thoughts & prayers when they don’t even keep the pews safe?" Ocasio-Cortez tweeted.

"When I saw that it just doubled down my determination to tell people," Kinzinger said. "Prayer means something, faith means something and I think even though we all have different faiths lets all stand together at this moment."

Prayer means something,  faith means something and I think even though we all have different faiths lets all stand together at this moment.

— Rep. Adam Kinzinger

"What's the balance between your freedoms? Your ability to do what you want on social media versus people who try to seek fame or notoriety through something like this," Kinzinger said.

"I don't know how to get a hold of this but we got to get to a society where people quit trying to chase this fame, this hollow fame whether it's through horrible actions or anything else. Be confident in who you are.  Go ahead with your life."

Fox News' Greg Norman contributed to this report.

Source: Fox News National

0 0

Rep. Ilhan Omar gets first 2020 endorsement from top-moneyed progressive advocacy group

A top-moneyed progressive advocacy group has awarded its first endorsement of the 2020 election cycle to embattled U.S. Rep. Ilhan Omar, who’s facing allegations of anti-Semitism and other controversies.

MoveOn.org announced its support for the Minnesota Democrat on Wednesday, saying it comes specifically because of criticism Omar has received following her comments.

FAR-LEFT MOVEON.ORG ASKS 2020 PRESIDENTIAL CANDIDATES TO SKIP PRO-ISRAEL AIPAC CONFERENCE

“Despite racist and anti-Muslim attacks to silence the first Black, Muslim congresswoman in the United States — and blatant attempts to incite violence against her and Muslim communities — Rep. Omar has continued to speak out for bold, progressive policies in order to fight for a society where all of us, not just the rich and powerful, can thrive,” the group’s statement reads.

“Despite racist and anti-Muslim attacks to silence the first Black, Muslim congresswoman in the United States ... Rep. Omar has continued to speak out for bold, progressive policies in order to fight for a society where all of us, not just the rich and powerful, can thrive.”

— MoveOn.org

But the endorsement may prove to be rather awkward for Omar who has long decried the influence of money in politics.

MoveOn has a huge war chest that is used exclusively to prop up Democratic candidates. In the 2018 election cycle, the group spent about $3.5 million, with millions going into running ads against Republicans.

Omar has recently drawn relentless critics over controversial comments. This week she was criticized after an old tweet resurfaced on social media in which she claimed U.S. forces killed “thousands” of Somalis during the 1993 “Black Hawk Down” mission – despite multiple analysts concluding the number was much smaller.

Earlier this month, Omar also faced controversy over her flippant comment during a Muslim advocacy group’s fundraiser where she referred to the Sept. 11, 2001, terror attacks as “some people did something.”

ILHAN OMAR CLAIMS US FORCES KILLED 'THOUSANDS' OF SOMALIS DURING 'BLACK HAWK DOWN' MISSION, RESURFACED TWEET SHOWS

In February, Omar drew bipartisan uproar after suggesting that politicians in the U.S. were bought by AIPAC (American Israel Public Affairs Committee), a non-partisan organization that seeks to foster the relationship between the U.S. and Israel.

“It’s all about the Benjamins baby,” Omar wrote in a now-deleted tweet, suggesting the group pays U.S. politicians to support Israel. AIPAC denied Omar’s claims that they fund politicians.

Omar issued an apology but reiterated a “problematic role of lobbyists” in politics, particularly AIPAC as well as the NRA and fossil fuel industry.

Just weeks later, Omar reignited the controversy, this time saying that supporters of Israel were pushing for U.S. politicians to declare “allegiance” to that nation.

“I want to talk about the political influence in this country that says it is OK for people to push for allegiance to a foreign country,” Omar said. “I want to ask why is it OK for me to talk about the influence of the NRA, of fossil fuel industries, or big pharma, and not talk about a powerful lobbying movement that is influencing policy?”

But MoveOn insists in its news release that its endorsement of Omar is no coincidence and that it fully stands behind her.

“During an era when moral clarity is of the utmost importance, we want to make it clear that Rep. Omar is definitely an important voice in Washington, D.C. — and in the country,” the group said.

CLICK HERE TO GET THE FOX NEWS APP

“The positive and bold progressive vision for our country that Congresswoman Ilhan Omar fights for every day is one that should be embraced by candidates everywhere — especially heading into 2020. Her fearlessness in advocating progressive policies is galvanizing the public in her district and throughout the country.”

Source: Fox News Politics

NOW ON AIR
Now On Air

Liberty #MAGAOne Mix

Via MAGA One Mix

6:00 am 8:00 am



FILE PHOTO: Jet Airways aircraft are seen parked at the Chhatrapati Shivaji Maharaj International Airport in Mumbai
FILE PHOTO: Jet Airways aircraft are seen parked at the Chhatrapati Shivaji Maharaj International Airport in Mumbai, India, April 18, 2019. REUTERS/Francis Mascarenhas/File Photo

April 26, 2019

By Aditi Shah and Abhirup Roy

NEW DELHI/MUMBAI (Reuters) – The grounding of India’s Jet Airways is turning into a quick windfall and long-term opportunity for international airlines keen to scoop up nearly a million outbound passengers from what was once the nation’s biggest airline.

Jet, which previously had a fleet of around 120 largely Boeing Co planes, was forced to indefinitely halt all flight operations on April 17 after its banks rejected the carrier’s plea for emergency funds.

The carrier’s descent into crisis has benefited international airlines in the form of rising fares and demand, data showed.

Fares from India to cities such as Dubai, London, New York, Singapore and Bali in the first quarter of 2019 rose between 4 percent and 32 percent from a year ago, according to Indian travel portal MakeMyTrip Ltd.

In the peak travel months of May and June, fares to London have spiked as much as 36 percent and tickets to San Francisco are up nearly 20 percent from a year ago, according to data from travel portal Yatra.com.

“For the next three months it’s actually bonanza time for international players,” said Ashish Nainan, a research analyst at CARE Ratings. “At least until the middle of June, the fares are not going to come down.”

Due to rising demand, even before Jet’s lessors grounded planes, carriers such as British Airways, Cathay Pacific Airways Ltd, Singapore Airlines Ltd and United Airlines saw an up to a 27 percent increase in passenger numbers from India in the last quarter of 2018, data from India’s aviation regulator showed. That is the latest period for which the data is available.

India is one of the world’s fastest-growing aviation markets, clocking 15-20 percent domestic growth in recent years. It has long had only two full-service long-haul carriers, state-run Air India and Jet.

Jet is now hoping to be bailed out by a new investor, with final bids due on May 10.

INCREASING CAPACITY

Before its grounding, Jet had the biggest share of India’s outbound international air traffic, carrying 12 percent of the 7.8 million passengers headed overseas in the Oct-Dec quarter, down from 14 percent a year earlier, data from the Directorate General of Civil Aviation showed.

For an interactive graphic on Jet’s market share, click https://tmsnrt.rs/2WvDQYi

For an interactive graphic on average daily flights by the airline, click https://tmsnrt.rs/2FeFDel

The total number of passengers traveling overseas with Jet fell 10 percent during the last quarter of 2018 even as the outbound travel market grew about 5 percent.

Meanwhile, Singapore Airlines posted a 27 percent increase in passengers from India, Cathay registered 17 percent growth and British Airways saw a 10 percent rise in the same period.

Cathay said the events at Jet combined with increasing demand for travel had led it to deploy larger aircraft with more seats on some Indian routes.

“In the long term we would certainly like to be able to offer more capacity into India, not just on our existing routes but by establishing new services to secondary cities,” Cathay said in a statement.

Singapore Airlines, in an email to Reuters, said the Indian market is “very promising” but declined to give details of airfare levels or demand patterns in the wake of Jet’s exit, citing a quiet period before the release of its annual results.

DOMESTIC GAINS

Jet’s grounding has also had a big impact on the domestic market, with inter-city air fares to major cities such as New Delhi, Mumbai, Bengaluru and Kolkata soaring more than 20 percent in May and June, according to Yatra.com.

The spike in fares is expected to underpin strong earnings for IndiGo and SpiceJet Ltd, which are set to report results for the quarter ended March 31 in the coming weeks.

“Domestic Indian carriers are the main benefactors, but I suspect if Jet fails to be revived by May 10 then Vistara and other airlines that ply international routes, particularly the lucrative Gulf market, are the main winners,” said Shukor Yusof, the head of aviation consultancy Endau Analytics. Vistara is a joint venture of India’s Tata Sons and Singapore Airlines.

Inadequate bilateral traffic rights between India and other countries, however, could be an impediment to foreign carriers’ hopes of winning business lost by Jet, some analysts said.

“Even before Jet’s operational shutdown, international capacity was significantly constrained,” said Kapil Kaul, CEO for South Asia of consultancy CAPA. “We have now more serious capacity challenge … this is unlikely to be stabilized in the near term.”

A new national government likely to be in place sometime after elections end in May is expected to address the international capacity constraints, and once bilateral agreements are eased airlines including Emirates, Turkish and Qatar would immediately benefit, said Kaul.

“We would love to add more flights but we are at the limit of the allocation granted to us for traffic rights,” Emirates Chief Commercial Officer Thierry Antinori told reporters in Dubai on Wednesday.

(Additional reporting by Alexander Cornwell in Dubai, Jamie Freed in Singapore and Tanvi Mehta in Mumbai; Editing by Muralikumar Anantharaman)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid

April 26, 2019

By Pushkala Aripaka and Ankur Banerjee

(Reuters) – AstraZeneca Plc beat first-quarter sales and earnings expectations on Friday as the British drugmaker benefited from a push into cancer drugs and emerging markets including China.

Newer treatments such as lung cancer drug Tagrisso, now the company’s top selling medicine, have helped the drugmaker’s return to growth after years of crumbling sales due to patent losses on older drugs.

Sales in China have shown explosive growth, more than doubling since 2012, but AstraZeneca executives on Friday said that may not be sustained.

“The enormous growth you currently see in China, 28 percent, probably is not sustainable, but we feel very bullish that the growth will continue to be at a pace of between 15 percent and 20 percent,” Ruud Dobber, executive vice president, BioPharma, told Reuters.

Shares of the company were down 0.2 percent at 5,878 pence at 1031 GMT.

The turnaround in AstraZeneca’s fortunes has been powered by a push into cancer treatments led by Chief Executive Pascal Soriot, who saw off a 2014 takeover bid from Pfizer in part by promising annual sales of $45 billion by 2023.

In the first quarter, sales from its oncology unit rose 59 percent to $1.89 billion, accounting for 35 percent of total product sales.

The company has moved deeper into cancer therapy market through wide-ranging deals, including those for immunotherapy and targeted therapy. Last month, it agreed a multi-billion dollar oncology deal with Japan’s Daiichi Sankyo Co Ltd.

Interactive graphic on AZN’s top 10 drugs by sales – https://tmsnrt.rs/2W5XIRX

“We’re reaching that point where after years of having to keep faith, we have actually got something tangible to believe in,” Hargreaves Lansdown analyst Nicholas Hyett said.

AstraZeneca also backed its annual sales and earnings forecast and said it has extensively prepared for UK’s anticipated exit from the European Union, even in the event of a no-deal exit.

The company has already spent more than 40 million pounds ($52 million) on Brexit preparations, including stockpiling six weeks’ worth of drugs in the UK and four weeks in continental Europe to guard against shortages.

AstraZeneca said product sales rose 14 percent at constant currency to $5.47 billion in the quarter, led by its lung cancer drug Tagrisso and respiratory treatment Pulmicort.

Interactive graphic on AZN’s quarterly oncology sales – https://tmsnrt.rs/2W9tbCD

China sales increased by 28 percent to $1.24 billion in the quarter, accounting for nearly a quarter of overall product sales.

Core earnings came in at 89 cents per share in the quarter. Analysts on average were expecting core earnings of 85 cents per share and product sales of $5.29 billion, according to a company provided consensus of 19 analysts.

(Reporting by Pushkala Aripaka and Ankur Banerjee in Bengaluru; Editing by Bernard Orr/Keith Weir)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

DNA Force Plus

Limited Advanced Release

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

Source: InfoWars

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

DNA Force Plus

Limited Advanced Release

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

Source: InfoWars

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

It’s the type of crime that doesn’t happen every day.

Police in the suburbs of Philadelphia say three suspects broke into a medical facility in Wynnewood, Pennsylvania, last Saturday and fled with 18 colonoscopies – devices used for examining the health of patients’ colons.

Suspects are seen leaving a medical facility in Wynnewood, Pa., allegedly carrying 18 colonoscopes worth about $450,000. (Lower Merion Police Department)

Suspects are seen leaving a medical facility in Wynnewood, Pa., allegedly carrying 18 colonoscopes worth about $450,000. (Lower Merion Police Department)

AMERICAN SUPERMODEL PAT CLEVELAND ‘STAYING STRONG’ FOLLOWING COLON CANCER DIAGNOSIS

The devices were reportedly worth a total of about $450,000, authorities said.

But police were perplexed about what the suspects might have planned to do with the instruments.

“This is not something that a typical pawn shop might accept,” Lower Merion Police Detective Sergeant Michael Vice told Philadelphia’s WCAU-TV. “My feeling would be that it was some type of black market sales.”

Such a market apparently does exist, Lower Merion Police Superintendent Michael J. McGrath told Philly.com.

CLICK HERE TO GET THE FOX NEWS APP

“They appeared to know precisely where to go, and they pried the door open,” McGrath said of the suspects, who were captured on surveillance video leaving the facility, carrying bulging backpacks.

Police are hoping the suspects will be caught in the end.

Source: Fox News National

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
Current track

Title

Artist